Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petar Lenert

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Drug Design, Development and Therapy|January 23, 2015
Current and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agentsAleksander Lenert, Petar Lenert
Cleveland Clinic Journal of Medicine|September 13, 2016
Gout and African Americans: Reducing disparitiesBharat Kumar, Petar Lenert
The American Journal of Medicine|March 14, 2017
Joint Hypermobility Syndrome: Recognizing a Commonly Overlooked Cause of Chronic PainBharat Kumar, Petar Lenert
Journal of Immunology (Baltimore, Md. : 1950)|February 9, 2005
Activation of marginal zone B cells from lupus mice with type A(D) CpG-oligodeoxynucleotidesRachel Brummel, Petar Lenert
Clinical Case Reports|September 21, 2016
Hypopyon complicating the course of anterior uveitis in a patient with Behcet's syndromeNamrata Singh, Petar Lenert
Clinical Rheumatology|November 30, 2016
Tapering biologics in rheumatoid arthritis: a pragmatic approach for clinical practiceAleksander Lenert, Petar Lenert
Immunologic Research|October 6, 2007
Structural requirements and applications of inhibitory oligodeoxyribonucleotidesRobert F Ashman, Petar Lenert
JAMA|August 29, 2020
A Patient With Back Pain and Morning StiffnessSameet Sangha, Petar Lenert, Bharat Kumar
Clinical Rheumatology|April 23, 2013
ANA (+) ANCA (+) systemic vasculitis associated with the use of minocycline: case-based reviewPetar Lenert, Michael Icardi, Laila Dahmoush
Current Allergy and Asthma Reports|November 17, 2011
Modulating toll-like receptor 7 and 9 responses as therapy for allergy and autoimmunityDamir Matesic, Aleksander Lenert, Petar Lenert
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Drug Design, Development and Therapy|January 23, 2015
Current and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agentsAleksander Lenert, Petar Lenert
Cleveland Clinic Journal of Medicine|September 13, 2016
Gout and African Americans: Reducing disparitiesBharat Kumar, Petar Lenert
The American Journal of Medicine|March 14, 2017
Joint Hypermobility Syndrome: Recognizing a Commonly Overlooked Cause of Chronic PainBharat Kumar, Petar Lenert
Journal of Immunology (Baltimore, Md. : 1950)|February 9, 2005
Activation of marginal zone B cells from lupus mice with type A(D) CpG-oligodeoxynucleotidesRachel Brummel, Petar Lenert
Clinical Case Reports|September 21, 2016
Hypopyon complicating the course of anterior uveitis in a patient with Behcet's syndromeNamrata Singh, Petar Lenert
Clinical Rheumatology|November 30, 2016
Tapering biologics in rheumatoid arthritis: a pragmatic approach for clinical practiceAleksander Lenert, Petar Lenert
Immunologic Research|October 6, 2007
Structural requirements and applications of inhibitory oligodeoxyribonucleotidesRobert F Ashman, Petar Lenert
JAMA|August 29, 2020
A Patient With Back Pain and Morning StiffnessSameet Sangha, Petar Lenert, Bharat Kumar
Clinical Rheumatology|April 23, 2013
ANA (+) ANCA (+) systemic vasculitis associated with the use of minocycline: case-based reviewPetar Lenert, Michael Icardi, Laila Dahmoush
Current Allergy and Asthma Reports|November 17, 2011
Modulating toll-like receptor 7 and 9 responses as therapy for allergy and autoimmunityDamir Matesic, Aleksander Lenert, Petar Lenert
Pageof 4